OB Flashcards
Goodell’s Sign
Softening of cervix at 4-6wk
Chadwick’s Sign
Bluish discolouration of cervix and vagina due to pelvic vasculature engorgement at 6wk
Hegar’s sign
Softening of cervical isthmus at 6-8wks
beta-hCG
Peptide hormone composed of alpha and beta subunits produced by placental trophoblastic cells
Maintains corpus luteum during pregnancy
beta hCG positive levels at…
9d post-conception in serum
28d after first day of LMP in urine
beta-hCG plasma level pattern
Doubles every 1.4-2d for first 4 weeks, then by 6-7wks may take 3d to double, peaks at 8-10wks then falls to plateau until delivery
beta-hCG levels less than expected suggest
Ectopic
Abortion
Inaccurate dates
May be normal
beta-hCG levels higher than expected suggest
Multiple gestation
Molar pregnancy
Trisomy 21
Inaccurate dates
beta-hCG rule of 10s
10IU = time of missed menses
100 000 IU = 10wk (peak)
10 000 IU = term
Transvaginal U/S finding at 5wks
Gestational sac
Transvaginal U/S finding at 6 wk
Fetal pole
Transvaginal U/S finding at 7-8wks
Fetal heart activity
Transabdominal U/S finding at 6-8wk
Intrauterine pregnancy visible
First trimester
1-14wks
Second trimester
14-28wks
Third trimester
28-42wks
Change in Hb and Hct in pregnancy
Decrease (physiologic anemia secondary to hemodilution)
Leukocyte count change in pregnancy
Increase but with impaired function
Gestational thrombocytopenia
Mild (plt >70 000) and asymptomatic, normalizes within 2-12wk
Hormone involved with delayed gastric emptying
Progesterone
Causes GERD, gallstones, constipation
Ureters and renal pelvis dilation in pregnancy
R>L
Secondary to progesterone induced sooth muscle relaxation and uterine enlargement
Renal function changes in pregnancy
Increased CO --> increased GFR Decreased Cr (35-44mmol/L), uric acid and BUN
Thyroid changes in pregnancy
Increased total thyroxine and thyroxine binding globulin
TSH levels are normal
Cortisol levels in pregnancy
Rise throughout
Calcium levels in pregnancy
Decreased total Calcium due to decreased albumin (free ionized Ca2+ remains the same due to parathyroid hormone)
Folic acid
8-12wks preconception until end of T1
Prevent NTDs
0.4-1mg daily in all women
5mg if previous NTD, antieplieptic meds, DM or BMI > 35kg/m2
Naegle’s Rule of dating
1st day of LMP + 1yr + 7d - 3mo
Dates should change if T1 U/S differs by…
> 5d in difference from LMP due date
Diclectin
10mg doxylamine succinate with Vitamin B6
4 tabs PO daily (1 qAM, 1qlunch, 2 qhs)
Up to max of 8 tabs/d
OB causes associated with hyperemesis
Multiple gestation
GTN
HELLP Syndrome
Kleihauer-Betke test
Extent of fetomaternal hemorrhage by estimating volume of fetal blood that entered maternal circulation
Situations when Rhogam is given to Rh neg women
Routinely at 28wk GA (protection for 12wk)
Within 72h of birth of an Rh+ fetus
Invasive procedure in pregnancy (CVS, amnio)
Ectopic preg
Miscarriage or therapeutic abortion
Antepartum hemorrhage
trauma
Tx for Rh neg and Ab pos mom
Follow serial monthly Ab titres throughout pregnancy, U/S +/- serial amnios as needed
Fetal hydrops
Edema in at least 2 fetal compartments due to fetal HF secondary to anemia
Erythroblastosis fetalis
Mod-severe immune-mediated hemolytic anemia
Risk factors for NTD
GRIMM
Genetics (risk of 2nd child having NTD is 2-5%, increased from baseline risk of 0.1%)
Race: Europeans>Africans, 3x higher in hispanics
Insufficient folate and zinc
Maternal chronic dz
maternal use of antiepileptics
Primigravidas feel fetal mvmt at
18-20wks
Normal EFM tracing
Baseline: 110-160bpm
Variability: 6-25bpm (< / = 5bpm for < 40min)
Decels: None, early decels, occasional uncomplicated, variable decels
Accels (term): Spontaneous, accels of >/= 15bpm lasting 15s
Accels (preterm): accels of > / = 10bpm last 10s
Accels present with scalp stim
Atypical EFM tracing
Baseline: 100-110 or >160 for <30min to < 80min
Variability: < / = 5bpm (absent or minimal) for 40-80min
Decels: Repetitive (> / = 3) uncomplicated variable decels. Occasional late decels. Single prolonged deceleration > 2 min but < 3 min
Accels: absence with fetal scalp stimulation
Abnormal EFM tracing
Baseline: Brady <100, tachy >160 for >80min
Variability: < 5 for > 80min, sinusoidal, >/=25bpm for >10min
Decels: Repetitive (> / = 3) complicated variable decels, late decels, any prolonged decel (> / = 3)
Accels: Nearly absent
Biophysical profile
U/S assessment +/- NST
Scoring: 2 points for each if reassuring
Tone (at least one epi of limb extension followed by flexion)
Movement (3 discrete mvmts)
breathing (at least one epi of breathing lasting at least 30s)
Amniotic fluid volume (fluid pocket of 2cm in 2 axes)
LAMB Limb extension and flexion AFV Movement Breathing
8-10 = normal 6 = unequivocal =4 = deliver
Daily caloric intake during pregnancy
100cal/d in 1st trimester
300 cal/d in 2nd and 3rd trimester
450 cal/d during lactation
Only nutrient for which requirements during pregnancy can’t be met by diet alone
Iron
Absolute C/I to exercise
Ruptured membranes preterm labour HTN d/o of preg Incompetent cervix IUGR Multiple gestations (>3) Placenta previa after 28th wk Persistent 2nd or 3rd trimester bleeding Unctrolled Type 1 DM Uncontrolled thyroid dz Other srs CV, resp or systemic d/o
Relative C/I to exercise
Previous preterm birth Mild/mod cv or resp d/o anemia (=100g/L) Malnutrition or eating d/o Twin preg after 28th wk
Smoking in pregnancy associated with
Decreased birth weight Placenta previa/abruption Spontaneous abortion Preterm labour Stillbirth
Cocaine in pregnancy associated with
Microcephaly
Growth retardation
Prematurity
Abruptio placentae
Marijuana in pregnancy associated with
Low birth weight
NSAIDs in pregnancy associated with
Premature closure of the ductus arteriosus after 30wks GA
Vaccines safe in pregnancy
Tetanus Diphtheria Influenza Hep B Pertussis
Vaccines recommended in pregnancy
Influenza
Tdap (irrespective of immunization hx) ideally btwn 27-32wks
Hepatitis B if maternal status unknown or positive
Hep B Vaccine and HBIG should be given to infant within 12h of birth with F/U doses at 1 and 6mo
Most common pathological etiology of obstetrical hemorrhage in T3
Abruptio placentae
Placenta previa
Abnormal location of placenta near, partially or completely over the internal cervical os
0.5-0.8% of all pregnancies
Painless bleeding
Abruptio placentae
Premature separation of a normally implanted placenta after 20wk GA
1-2% of all pregnancies
Painful bleeding
Placenta previa risk factors
- Hx of placenta prevue (4-8% recurrence risk)
- Multiparity
- Increased maternal age
- Multiple gestation
- Uterine tumour (ie. fibroids) to other uterine anomalies
- Uterine scar due to previous abortion, C/S, D&C, myomectomy
Abruptio placenta risk factors
- Previous abruption (recurrence rate 5-16%)
- Maternal HTN (chronic or gestational HTN in 50% of abruptions) or vascular dz
- Cigarette smoking (>1 pack/d), excessive EtOH consumption, cocaine
- Multiparity and/or maternal age >35yr
- PPROM
- Rapid decompression of a distended uterus (polyhydramnios, multiple gestation)
- Uterine anomaly, fibroids
- Trauma
Spontaneous resolution of placenta previa is likely if…
placenta obscures internal os by <20mm at 20wk GA
Transvaginal U/S should be repeated in third trimester
NIPT
Analyzes blood for circulating cell free fetal DNA at 9-10wk GA onwards
Highly sensitive/specific for Trisomy 21 (can also look for tri 18, 13 and some X and Y disorders)
Doesn’t screen for ONTD
NIPT indications
> 35 yo
Abnormal prenatal screen (IPS, FTS or MSS)
Past hx of fam hx of: chromosomal anomaly or genetic dz, either parent a known carrier of a genetic d/o, consanguinity, >3 spontaneous abortions
Amniocentesis
U/S guided transabdominal extraction of amniotic fluid performed as early as 15wks GA
Screens for genetic anomalies and ONTD
Assessment of fetal lung maturity (T3) via L/S ratio (lecitihin:sphingomyelin), if >2:1 RDS is less likely to occur
Amniocentesis indications
Confirmation of positive NIPT
Positive FTS/IPS
Chorionic villus sampling
Biopsy of fetal derived chorion using transabdominal needle or transcervical catheter at 10-12wk
Screens for genetic d/o (rapid karyotyping and biocehmcial assay)
Does not screen for ONTD
Most common cause of DIC in pregnancy
Abruptio placentae
Dx of abruptio placentae
Clinical
U/S not sensitive for dx abruption
Stable abruption <37wk GA
Use serial Hct to assess concealed bleeding, deliver when feetus mature or when hemorrhage dictates
Stable abruption >/= 37wk
Deliver
Unstable abruption
Deliver (vaginal if no C/I, C/S otherwise)
Vasa previa
- Unprotected fetal vessels pass over cervical os
- A/W velamentous insertion of cord into membranes of placenta or accessory (succenturiate) lobe
- 1 in 500 deliveries
- Higher in twin pregnancies
- PAINLESS vaginal bleeding and fetal distress
- 50% perinatal mortality, increases to 75% if membranes rupture
Dx of vasa previa
Apt test
Wright stain on blood smear
Apt test
NaOH mixed with blood
Supernatant turns pink = fetal blood
Supernatant turns yellow = maternal blood
Wright stain on blood smear
Nucleated cells indicate cord blood
Tx of vasa previa
Planned C/s at 35-36wk
If bleeding, emergency C/S
Preterm labour
20-37wks GA
Most important risk factor for preterm labour
Previous history of spontaneous PTL
Cervical cerclage
Placement of cervical sutures at level of internal os, usually at end of first trimester (usually 12-12wk) or in second trimester and removed in third trimester
Progesterone to prevent preterm labour
- If previous PTL: 17-alphahydroxyprogesterone 250mg IM weekly from 16 - 36wks GA
- If short cervix: 200mg daily vaginally from time of dx to 36wks GA
Fetal fibronectin
Glycoprotein in amniotic fluid and placental tissue
+ve if >50ng/mL
Done only if 24-34wks, intact membranes, <3cm dilated, establish fetal well being
C/I if : cerclage, active vaginal bleeding, vag exam or sex in last 24h
If -ve: not likely to deliver in 7-14d
If +ve: increased risk of delivery
Tocolysis
Delays delivery for at least 48h for betamethasone valerate to work or for transfer to appropriate care centre
Only to be given if live, immature fetus, intact membranes, cervical dilatation of <4cm
Tocolytic agents
Nifedipine (20mg PO loading dose followed by 20mg PO 90min later, 20mg can be continued q3-8h for 72h or to a max of 180mg, 10mg PO q20min x 4doses)
Indomethacin = prostaglandin synthesis inhibitor, 1st line for early preterm labour (50-100mg PR loading dose followed by 50mg q6h x 8 doses for 48h)
Antenatal corticosteroids
Betamethasone valerate (12mg IM q24h x 2 doses)
Dexamethasone (6mg IM q12h x 4 doses)
Given btwn 24-36+6wks GA
Specific maternal C/I: Active TB
Prolonged ROM
> 24h elapsed btwn rupture of membranes and onset of labour
PPROM
<37wks GA and premature rupture of membranes
PPROM investigations
Pooling Cough test Nitrizine (blue) Ferning U/S
Antibiotics in PPROM
Give if there are no signs of immediate labour
Increases latency and decreases chorioamniotis
Ampicillin IV + Erythro IV x 48h then Amox PO x 5d + erythro PO x 5d OR just erythro PO x 10d
Postterm pregnancy IOL
> 39wks GA in advanced maternal age
>41wks GA if vagian ldelivery not C/I
Fetal demise
Fetal death after 20wks GA
Obstetrical causes of DIC
Abruption
Gestational HTN
Fetal demise
PPH
DIC specific b/w
Plt
aPTT and PT
FDP
Fibrinogen
DIC tx
Treat underlying cause Supportive Fluids Blood products FFP, plt, cryoprecipitate Consider anti-coagulation as VTE prophylaxis
IUGR
Estimated fetal weight <10th percentile for GA on U/S
TORCH infections
Toxoplasmosis Others (ie. syphilis) Rubella CMV HSV
Most important risk factor for IUGR
Previous IUGR
Symmetric/Type I IUGR
25-30%
Occurs early in pregnancy
* Reduced growth of both head and abdominal
* Head:Abdo ratio may be normal
* Usually a/w with congenital anomalies or TORCH infections
Asymmetric/Type II IUGR
70%
Occurs late in pregnancy
* Fetal abdo is disproportionately smaller than fetal head
* Brain is spared (Head:abdo ratio is increased)
* Usually a/w placental insufficiency
* More favourable prognosis than type I
Macrosomia
Infant weight >/=90th percentile for a particular GA or >4000g
U/S predictors of macrosomia
Polyhydramnios
Third trimester AC > 1.5cm/wk
HC/AC ratio <10th percentile
FL/AC ratio <20th percentile
Prophylactic C/S for macrosomia
EFW > 5000g in non-diabetic woman
EFW > 4500g in diabetic woman
Polyhydramnios
AFI>25cm
U/S deepest pocket >8cm
Management: mild-mod require no tx, severe should be hospitalized and consider therapeutic amnio
Oligohydramnios
AFI <5cm
U/S deepest pocket =2cm
Management: Admit, investigate, maternal hydration PO or IV, inject fluid via amnio, consider delivery
Med associated with oligohydramnios
ACEi
U/S frequency for multiple gestation
Serial U/S q2-3wk from 24wk GA to assess growth (uncomplicated didi)
Increased freq in monodi and monomono)
Vaginal delivery possible for twins if…
Twin A presents vertex